Food Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mg

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The objective of this study was to investigate the single-dose relative bioavailability of Mylan\'s oxybutynin chloride extended-release tablets to ALZA\'s Ditropan XL® tablets following an oral, single 20 mg (2 x 10 mg) dose under fed conditions.
Epistemonikos ID: 815d91c4b0c41f5590ab76a65b37b9b52aae48de
First added on: May 04, 2024